9 Amendments of Elissavet VOZEMBERG-VRIONIDI related to 2020/2071(INI)
Amendment 8 #
Draft opinion
Recital A a (new)
Recital A a (new)
A a. whereas the problem of the shortage of medicines in the Member States is increasingly observed, due to economic and regulatory burdens, unforeseen surges of demand and supply chain bottlenecks in manufacturing and quality insurance.
Amendment 11 #
Draft opinion
Recital B a (new)
Recital B a (new)
B a. whereas any EU strategy to address medicine shortages should be a wholesome approach that takes into consideration the root causes of medicines shortages and that addresses concrete actions for their prevention. The Union needs to focus on ways to increase production of medicines in Europe avoiding any future recurrence of shortages during a crisis and avoiding dependency on third countries for pharmaceutical ingredients.
Amendment 19 #
Draft opinion
Recital C a (new)
Recital C a (new)
C a. whereas the coronavirus pandemic highlighted the importance of coordinated action between EU institutions, Member States and industry in order to mitigate supply disruptions of medicines.
Amendment 22 #
Draft opinion
Recital C b (new)
Recital C b (new)
C b. whereas the COVID-19 exacerbated the existing situation, and highlighted that the pharmaceutical supply chain is interconnected within EU Members States and externally;
Amendment 48 #
Draft opinion
Paragraph 3
Paragraph 3
3. Calls on the Member States to adopt strategic plans to upgrade their existing infrastructure for an efficient supply of medicines; deems it necessary to remove bottlenecks, boost intermodality (while favouring the shift to rail), finance the main hubs (ports, airports and intermodal platforms), and enhance the delivery of various types of goods, including dangerous goods crucial for the production of the chemical and pharmaceutical industryto ensure the uninterrupted import and export of essential goods, such as medicines and medical goods;
Amendment 59 #
Draft opinion
Paragraph 5
Paragraph 5
5. Notes the importance of guaranteeing non-discriminatory high safety standards for both transport infrastructure and employeetransport workers, making it possible to manage significant volumes in the supply chain without disruptions or posing risks to health;
Amendment 62 #
Draft opinion
Paragraph 5 a (new)
Paragraph 5 a (new)
5 a. Call on the Commission to support Member States, in extraordinary circumstances in order to ensure reserved space in all cargo to essential goods (such as medicines, active pharmaceutical ingredients, medical equipment, etc).
Amendment 76 #
Draft opinion
Paragraph 7
Paragraph 7
7. Notes that the COVID-19 outbreak has laid bare the weaknesses of the European production system, highlighting the importance of delivering medicines swiftly in urgent and exceptional circumstances that could arise in the futureighlighted the importance of ensuring circulation and timely delivery of goods in extraordinary circumstances.
Amendment 80 #
Draft opinion
Paragraph 7 a (new)
Paragraph 7 a (new)
7 a. Calls on the Commission to immediately activate European and global cooperation, during crisis events, to prioritise the circulation intra-EU or extra-EU of essential goods, such as medicines, active pharmaceutical ingredients, intermediates, key starting materials ingredients, etc, to maintain road, ports, airport traffic flowing by creating priority “Green lanes” within Member States and between EU and third countries, and within those countries, for these essential goods.